{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T14:14:49Z","timestamp":1778076889492,"version":"3.51.4"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To analyze the pathogen distribution of older type 2 diabetes mellitus (T2DM) patients with urinary tract infection (UTI) and to develop and validate the feasibility of a nomogram risk prediction model for older T2DM patients with UTI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analyzed clinical data from older patients with T2DM admitted to the Department of Endocrinology of The First People\u2019s Hospital of Lianyungang City from December 2023 to December 2024. Random number sequences were generated using R software, and all patients were assigned to the modeling cohort and validation cohorts in a ratio of 7:3 through simple random sampling. We compared baseline features between training and validation sets using appropriate statistical tests. We employed univariate and multivariate logistic regression models to identify factors independently associated with UTI in older patients with T2DM. Subsequently, we developed a nomogram prediction model, which was then validated using the validation group. Four methods of statistics, namely, the Hosmer\u2013Lemeshow goodness-of-fit test (H-L test), subjects\u2019 work characteristic curve and area under the curve (AUC), calibration curve, and clinical decision curve (DCA), were comprehensively applied to evaluate the model\u2019s fit, discrimination, calibration, and clinical utility.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 521 older patients with T2DM, 82 developed UTI, with an incidence of 15.74%. Logistic regression analyses identified female (odds ratio [OR] = 2.53, 95% confidence interval [CI]: 1.25\u20135.12,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.011), HbA1c (OR = 1.35, 95% CI: 1.15\u20131.59,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.001), SGLT-2i in previous year (OR = 2.29, 95% CI: 1.19\u20134.41,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.013), indwelling urinary catheter (OR = 3.04, 95% CI: 1.02\u20139.23,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.048), and UTI in previous year (OR = 5.22, 95% CI: 2.22\u201312.25,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.001) as independent risk factors for older T2DM patients with UTI. The AUC was 0.779 (95% CI: 0.703\u20130.855) in the training group and 0.793 (95% CI:0.691\u20130.896) in the validation group. The H-L test results for the training (\u03c7\u00b2 = 9.834,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.277) and validation (\u03c7\u00b2 = 5.432,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.711) groups indicated good goodness-of-fit for the prediction model, with the internal validation curve demonstrating satisfactory performance.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Establishing this simple, intuitive nomogram prediction model enables the early identification of risk factors in older T2DM patients with UTI. Based on readily accessible clinical variables, this model facilitates early risk stratification and promotes preventive interventions in a timely manner, ultimately reducing UTI incidence in clinical practice. Furthermore, the identified pathogen distribution and antimicrobial susceptibility profiles directly support targeted UTI treatment in this high-risk population, further enhancing the clinical utility of the predictive model and potentially improving patient outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1706338","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T05:25:54Z","timestamp":1769491554000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and validation of a prediction model for urinary tract infection in older patients with type 2 diabetes mellitus"],"prefix":"10.3389","volume":"17","author":[{"given":"Lin","family":"Yang","sequence":"first","affiliation":[{"name":"Hospital-Acquired Infection Control Department, The Affiliated Lianyungang Hospital of Xuzhou Medical University","place":["Lianyungang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Yin","sequence":"additional","affiliation":[{"name":"Hospital-Acquired Infection Control Department, The Affiliated Lianyungang Hospital of Xuzhou Medical University","place":["Lianyungang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengxiong","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Affiliated Lianyungang Hospital of Xuzhou Medical University","place":["Lianyungang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[{"name":"Hospital-Acquired Infection Control Department, The Affiliated Lianyungang Hospital of Xuzhou Medical University","place":["Lianyungang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.12114\/j.issn.1007-9572.2024.0497","article-title":"Investigation and future trend prediction of disease burden of elderly type 2 diabetes mellitus globally and in China from 1990 to 2021","volume":"28","author":"Zhao","year":"2025","journal-title":"Chin Gen Pract"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1016\/j.cmet.2024.10.004","article-title":"Hyperglycemia-triggered lipid peroxidation destabilizes stat4 and impairs anti-viral th1 responses in type 2 diabetes","volume":"36","author":"Gray","year":"2024","journal-title":"Cell Metab"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2174\/1573399815666191024085838","article-title":"Type 2 diabetes and its impact on the immune system","volume":"16","author":"Berbudi","year":"2020","journal-title":"Curr Diabetes Rev"},{"key":"B4","doi-asserted-by":"publisher","first-page":"7105","DOI":"10.3390\/ijms25137105","article-title":"Pathology of diabetes-induced immune dysfunction","volume":"25","author":"Alexander","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2021.05.013","article-title":"An update on the epidemiology of type 2 diabetes: A global perspective","volume":"50","author":"Tinajero","year":"2021","journal-title":"Endocrinol Metab Clinics North America"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.7860\/jcdr\/2017\/25019.9662","article-title":"Clinical and laboratory profile of urinary tract infections in type 2 diabetics aged over 60 years","volume":"11","author":"Sharma","year":"2017","journal-title":"J Clin Diagn research: JCDR"},{"key":"B7","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40001-022-00644-9","article-title":"The prevalence of urinary tract infections in type 2 diabetic patients: A systematic review and meta-analysis","volume":"27","author":"Salari","year":"2022","journal-title":"Eur J Med Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"9427","DOI":"10.3390\/ijerph17249427","article-title":"Time trends in Spain from 2001 to 2018 in the incidence and outcomes of hospitalization for urinary tract infections in patients with type 2 diabetes mellitus","volume":"17","author":"L\u00f3pez-de-Andr\u00e9s","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-0653","article-title":"Trends in Rates of Infections Requiring Hospitalization among Adults with Versus without Diabetes in the U.S., 2000-2015","volume":"43","author":"Harding","year":"2020","journal-title":"Diabetes Care"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2147\/idr.S251966","article-title":"Blood neutrophil-to-lymphocyte ratio and urine il-8 levels predict the type of bacterial urinary tract infection in type 2 diabetes mellitus patients","volume":"13","author":"Saheb Sharif-Askari","year":"2020","journal-title":"Infect Drug Resist"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2012.02.026","article-title":"Sepsis in diabetes: A bad duo","volume":"5","author":"Tiwari","year":"2011","journal-title":"Diabetes Metab syndrome"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e0303557","DOI":"10.1371\/journal.pone.0303557","article-title":"Sepsis risk in diabetic patients with urinary tract infection","volume":"19","author":"Wang","year":"2024","journal-title":"PloS One"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2024.2307346","article-title":"Risk prediction models of mortality after hip fracture surgery in older individuals: A systematic review","volume":"40","author":"Sun","year":"2024","journal-title":"Curr Med Res Opin"},{"key":"B14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s10654-006-9077-y","article-title":"Prediction of complicated urinary tract infections in patients with type 2 diabetes: A questionnaire study in primary care","volume":"22","author":"Venmans","year":"2007","journal-title":"Eur J Epidemiol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1017\/s0950268808001015","article-title":"A clinical prediction rule for urinary tract infections in patients with type 2 diabetes mellitus in primary care","volume":"137","author":"Venmans","year":"2009","journal-title":"Epidemiol infection"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1006-2483.2025.04.033","article-title":"Pathogenic bacteria and risk factors of urinary tract infection in elderly patients with type 2 diabetes mellitus and construction of prediction model","volume":"36","author":"Tu","year":"2025","journal-title":"J Public Health Prev Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1259596","article-title":"A personalized prediction model for urinary tract infections in type 2 diabetes mellitus using machine learning","volume":"14","author":"Xiong","year":"2023","journal-title":"Front Pharmacol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3760\/cma.j.cn115791-20241203-00705","article-title":"Guideline for the prevention and treatment of diabetes mellitus in China (2024 edition)","volume":"17","year":"2025","journal-title":"Chin J Diabetes Mellitus"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.16766\/j.cnki.issn.1674-4152.003532","article-title":"Interpretation of key points from the \u201cEau guidelines on urological infections (2023)","volume":"22","author":"Liu","year":"2024","journal-title":"Chin J Gen Pract"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e0162323","DOI":"10.1128\/jcm.01623-23","article-title":"Overview of changes in the clinical and laboratory standards institute performance standards for antimicrobial susceptibility testing: M100 32nd and 33rd editions","volume":"63","author":"Schuetz","year":"2025","journal-title":"J Clin Microbiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e0310903","DOI":"10.1371\/journal.pone.0310903","article-title":"Risk factors for urinary tract infection in elderly patients with type 2 diabetes: A protocol for systematic review and meta-analysis","volume":"19","author":"Jia","year":"2024","journal-title":"PloS One"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-018-1116-0","article-title":"Sglt-2 inhibitors and the risk of infections: A systematic review and meta-analysis of randomized controlled trials","volume":"55","author":"Puckrin","year":"2018","journal-title":"Acta diabetologica"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/s0895-4356(96)00236-3","article-title":"A simulation study of the number of events per variable in logistic regression analysis","volume":"49","author":"Peduzzi","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.11816\/cn.ni.2024-231119","article-title":"Etiological characteristics, drug resistance and risk factors for urinary tract infection in type 2 diabetes mellitus patients","volume":"34","author":"Xue","year":"2024","journal-title":"Chin J Nosocomiology"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.13350\/j.cjpb.191022","article-title":"Analysis of pathogen distribution, the oxidative stress index, and related factors in patients with type 2 diabetes and a urinary tract infection","volume":"14","author":"Yong","year":"2019","journal-title":"J Pathogen Biol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.11816\/cn.ni.2017-170114","article-title":"Distribution and drug resistance of pathogentic bacteria and related factors in patients with type 2 diabetes mellitus complicated with urinary tract infections","volume":"27","author":"Liu","year":"2017","journal-title":"Chin J Nosocomiology"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-024-01537-3","article-title":"Diabetes, SGLT-2 inhibitors, and urinary tract infection: A review","volume":"24","author":"Pishdad","year":"2024","journal-title":"Curr Diabetes Rep"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.56434\/j.arch.esp.urol.20247703.37","article-title":"Risk factors for urinary tract infection in elderly patients with type 2 diabetes: A retrospective cohort study","volume":"77","author":"Ni","year":"2024","journal-title":"Arch Esp Urol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.2147\/dmso.S402156","article-title":"Prevalence and associated factors of urinary tract infection in patients with diabetic neuropathy: A hospital-based cross-sectional study","volume":"16","author":"Wang","year":"2023","journal-title":"Diabetes Metab syndrome obesity: Targets Ther"},{"key":"B30","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.chom.2020.06.022","article-title":"The urinary tract microbiome in older women exhibits host genetic and environmental influences","volume":"28","author":"Adebayo","year":"2020","journal-title":"Cell Host Microbe"},{"key":"B31","doi-asserted-by":"publisher","first-page":"28386","DOI":"10.1038\/s41598-024-80116-8","article-title":"U-shaped association between HbA1c and all-cause mortality in CVD patients with diabetes","volume":"14","author":"Yu","year":"2024","journal-title":"Sci Rep"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1006-6187.2023.09.013","article-title":"Research progress on the role of glycosylation end products advanced in cardiovascular disease of type 2 diabetes mellitus","volume":"31","author":"Dai","year":"2023","journal-title":"Chin J Diabetes"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1172\/jci124922","article-title":"Why are diabetics prone to kidney infections","volume":"128","author":"Zasloff","year":"2018","journal-title":"J Clin Invest"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.12669\/pjms.36.7.2881","article-title":"Diabetes mellitus and urinary tract infection: causative uropathogens, their antibiotic susceptibility pattern and the effects of glycemic status","volume":"36","author":"Ahmad","year":"2020","journal-title":"Pakistan J Med Sci"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocpiqo.2022.08.004","article-title":"Reducing Catheter-Associated Urinary Tract Infections across a Hospital System through Urine Culture Stewardship","volume":"6","author":"Kalorin","year":"2022","journal-title":"Mayo Clinic Proc Innovations Qual outcomes"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-012-0934-x","article-title":"Prevalence of urinary tract infection and risk factors among saudi patients with diabetes","volume":"31","author":"Al-Rubeaan","year":"2013","journal-title":"World J Urol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13820","article-title":"Sodium glucose cotransporter 2 inhibitors and risk of genital mycotic and urinary tract infection: A population-based study of older women and men with diabetes","volume":"21","author":"Lega","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01471-2","article-title":"Adverse drug events observed with the novel sodium\/glucose co-transporter 2 inhibitor ipragliflozin for the treatment of patients with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized studies","volume":"37","author":"Liu","year":"2020","journal-title":"Adv Ther"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-159-4-201308200-00007","article-title":"Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes: A systematic review and meta-analysis","volume":"159","author":"Vasilakou","year":"2013","journal-title":"Ann Internal Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1238399","article-title":"Comparative safety of different sodium-glucose transporter 2 inhibitors in patients with type 2 diabetes: A systematic review and network meta-analysis of randomized controlled trials","volume":"14","author":"Li","year":"2023","journal-title":"Front Endocrinol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn441217\u221220230625\u221200633","article-title":"Chinese expert consensus on the clinical application of sodium\u2212Glucose transporter 2 inhibitors in patients with chronic kidney disease","volume":"15","year":"2023","journal-title":"Chinese Journal of Diabetes Mellitus"},{"key":"B42","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12933-022-01512-w","article-title":"The current role of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes mellitus management","volume":"21","author":"Xu","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-020-0324-0","article-title":"Urinary tract infections: microbial pathogenesis, host\u2013pathogen interactions and new treatment strategies","volume":"18","author":"Klein","year":"2020","journal-title":"Nat Rev Microbiol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112138-20250924-00572","article-title":"National guidelines for the prevention and control of diabetes in primary care (2025)","volume":"64","year":"2025","journal-title":"Chin J Internal Med"}],"updated-by":[{"DOI":"10.3389\/fendo.2026.1863109","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000}}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1706338\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T13:18:50Z","timestamp":1778073530000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1706338\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":44,"alternative-id":["10.3389\/fendo.2026.1706338"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1706338","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"article-number":"1706338"}}